SQI Diagnostics Inc. (SQIDF)
SQI Diagnostics Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.01, up 14.62% on the session, giving a market capitalisation of $6.1M. On trailing twelve-month figures it carries a trailing P/E of -0.44, a net margin of -228.6%. Its beta of -0.36 implies it has historically moved less than the broad market.
SQI Diagnostics Inc. operates as a precision medicine firm, engaged in the global identification, advancement, and marketing of swift diagnostic solutions tailored for medical professionals, patients, and the general public. Its diverse product portfolio features TOR-dx, a specialized lung test designed to help surgeons evaluate the condition of donor lungs. The company also offers an at-home antibody test kit for COVID-19, along with RALI-Dx, a laboratory-based test for triaging COVID-19 severity, and RALI-fast, its rapid point-of-care alternative for the same purpose. Furthermore, SQI Diagnostics provides essential microarray instruments to support antibody testing procedures. The company was founded in 1999 and maintains its corporate headquarters in Toronto, Canada.
SQI Diagnostics Inc. is most often compared with the following Healthcare names: